Responses
Scientific Abstracts
Oral Presentations
New Developments in COVID-Research
OP0282 RITUXIMAB ASSOCIATED WITH SEVERE COVID-19 AMONG PATIENTS WITH INFLAMMATORY ARTHRITIDES: A 1-YEAR MULTICENTER STUDY IN 1116 SUCCESSIVE PATIENTS RECEIVING BIOLOGIC AGENTS
Compose a Response to This Article
Other responses
No responses have been published for this article.